The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Prediction of antibiotic resistance: time for a new preclinical paradigm?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Self-citationMechanisms of, and Barriers to, Horizontal Gene Transfer between Bacteria
Thomas, C. M., & Nielsen, K. M. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1234 · Cited by 2,183
Drake, J. W., Charlesworth, B., Charlesworth, D., & Crow, J. F. (1998) · Genetics · doi:10.1093/genetics/148.4.1667 · Cited by 1,932
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
Self-citationSelection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Self-citationMolecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins
Weinreich, D. M., Delaney, N. F., DePristo, M. A., & Hartl, D. L. (2006) · Science · doi:10.1126/science.1123539 · Cited by 1,415
Bacterial phylogeny structures soil resistomes across habitats
Forsberg, K. J., Patel, S., Gibson, M. K., Lauber, C. L., Knight, R., Fierer, N., & Dantas, G. (2014) · Nature · doi:10.1038/nature13377 · Cited by 1,287
Evolution of the mutation rate
Lynch, M. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.003 · Cited by 1,151
Functional characterization of the antibiotic resistance reservoir in the human microflora
Sommer, M. O. A., Dantas, G., & Church, G. M. (2009) · Science · doi:10.1126/science.1176950 · Cited by 878
Self-citationMathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
The biological cost of antibiotic resistance
Andersson, D. I., & Levin, B. R. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00005-3 · Cited by 867
Self-citationEmpirical fitness landscapes and the predictability of evolution
de Visser, J. A. G. M., & Krug, J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3744 · Cited by 715
Long-Term Dynamics of Adaptation in Asexual Populations
Wiser, M. J., Ribeck, N., & Lenski, R. E. (2013) · Science · doi:10.1126/science.1243357 · Cited by 591
Selection of a Multidrug Resistance Plasmid by Sublethal Levels of Antibiotics and Heavy Metals
Gullberg, E., Albrecht, L. M., Karlsson, C., Sandegren, L., & Andersson, D. I. (2014) · mBio · doi:10.1128/mbio.01918-14 · Cited by 559
Self-citationFunctional metagenomics reveals diverse β-lactamases in a remote Alaskan soil
Allen, H. K., Moe, L. A., Rodbumrer, J., Gaarder, A., & Handelsman, J. (2009) · The ISME Journal · doi:10.1038/ismej.2008.86 · Cited by 500
Enne, V. I., Livermore, D. M., Stephens, P., & Hall, L. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04519-0 · Cited by 486
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko, G. E., Yagi, B. H., Schaadt, R. D., Allison, J. W., Kilburn, J. O., Glickman, S. E., Hutchinson, D. K., Barbachyn, M. R., & Brickner, S. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.839 · Cited by 461
Imamovic, L., & Sommer, M. O. A. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006609 · Cited by 444
Self-citationThe genetic basis of the fitness costs of antimicrobial resistance: a meta‐analysis approach
Vogwill, T., & MacLean, R. C. (2015) · Evolutionary Applications · doi:10.1111/eva.12202 · Cited by 443
Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
Schrag, S. J., Perrot, V., & Levin, B. R. (1997) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1997.0178 · Cited by 396
George, A. M., & Levy, S. B. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.531-540.1983 · Cited by 352
The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
Molton, J. S., Tambyah, P. A., Ang, B. S. P., Ling, M. L., & Fisher, D. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit020 · Cited by 342
Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
Marcusson, L. L., Frimodt-Møller, N., & Hughes, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000541 · Cited by 320
Gilmore, M. S., Lebreton, F., & van Schaik, W. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.01.006 · Cited by 306
Methods for determining spontaneous mutation rates
Foster, P. L. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(05)09012-9 · Cited by 302
Amelioration of the Cost of Conjugative Plasmid Carriage in Eschericha coli K12
Dahlberg, C., & Chao, L. (2003) · Genetics · doi:10.1093/genetics/165.4.1641 · Cited by 291
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance
Palmer, A. C., & Kishony, R. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3351 · Cited by 285
Initial Mutations Direct Alternative Pathways of Protein Evolution
Salverda, M. L. M., Dellus, E., Gorter, F. A., Debets, A. J. M., van der Oost, J., Hoekstra, R. F., Tawfik, D. S., & de Visser, J. A. G. M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001321 · Cited by 275
Oz, T., Guvenek, A., Yildiz, S., Karaboga, E., Tamer, Y. T., Mumcuyan, N., Ozan, V. B., Senturk, G. H., Cokol, M., Yeh, P., et al. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu191 · Cited by 275
Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids
Millan, A. S., Peña-Miller, R., Toll-Riera, M., Halbert, Z. V., McLean, A. R., Cooper, B. S., & MacLean, R. C. (2014) · Nature Communications · doi:10.1038/ncomms6208 · Cited by 264
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus
Nagaev, I., Björkman, J., Andersson, D. I., & Hughes, D. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02389.x · Cited by 257
Self-citationKahlmeter, G., & Poulsen, H. O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.013 · Cited by 256
Positive Epistasis Drives the Acquisition of Multidrug Resistance
Trindade, S., Sousa, A., Xavier, K. B., Dionisio, F., Ferreira, M. G., & Gordo, I. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000578 · Cited by 252
Lázár, V., Nagy, I., Spohn, R., Csörgő, B., Györkei, Á., Nyerges, Á., Horváth, B., Vörös, A., Busa-Fekete, R., Hrtyan, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5352 · Cited by 249
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
Self-citationBiological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli
Nilsson, A. I., Berg, O. G., Aspevall, O., Kahlmeter, G., & Andersson, D. I. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2850-2858.2003 · Cited by 241
Self-citationPopulation biological principles of drug-resistance evolution in infectious diseases
zur Wiesch, P. A., Kouyos, R., Engelstädter, J., Regoes, R. R., & Bonhoeffer, S. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70264-4 · Cited by 240
Survival and Evolution of a Large Multidrug Resistance Plasmid in New Clinical Bacterial Hosts
Porse, A., Schønning, K., Munck, C., & Sommer, M. O. A. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw163 · Cited by 237
Self-citationThe CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones
Naseer, U., & Sundsfjord, A. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0132 · Cited by 236
Positive epistasis between co-infecting plasmids promotes plasmid survival in bacterial populations
Millán, Á. S., Heilbron, K., & MacLean, R. C. (2013) · The ISME Journal · doi:10.1038/ismej.2013.182 · Cited by 223
Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations
Sander, P., Springer, B., Prammananan, T., Sturmfels, A., Kappler, M., Pletschette, M., & Böttger, E. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1204-1211.2002 · Cited by 213
Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis
Feldman, W. E. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80003-0 · Cited by 212
Present aspects of bacterial resistance in tuberculosis.
Canetti, G. (1965) · PubMed · doi:10.1164/arrd.1965.92.5.687 · Cited by 211
Pena-Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernandez, A., Rosenstiel, P., Schulenburg, H., & Beardmore, R. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001540 · Cited by 209
Limited dissemination of the wastewater treatment plant core resistome
Munck, C., Albertsen, M., Telke, A., Ellabaan, M., Nielsen, P. H., & Sommer, M. O. A. (2015) · Nature Communications · doi:10.1038/ncomms9452 · Cited by 207
Self-citationLocke, J. B., Hilgers, M., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-09 · Cited by 205
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
Sandegren, L., Lindqvist, A., Kahlmeter, G., & Andersson, D. I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn222 · Cited by 196
Self-citationCavitary Disease and Quantitative Sputum Bacillary Load in Cases of Pulmonary Tuberculosis
Palaci, M., Dietze, R., Hadad, D. J., Ribeiro, F. K. C., Peres, R. L., Vinhas, S. A., Maciel, E. L. N., do Valle Dettoni, V., Horter, L., Boom, W. H., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01780-07 · Cited by 192
Sundqvist, M., Geli, P., Andersson, D. I., Sjolund-Karlsson, M., Runehagen, A., Cars, H., Abelson-Storby, K., Cars, O., & Kahlmeter, G. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp387 · Cited by 179
Self-citationMunck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H., & Sommer, M. O. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009940 · Cited by 178
Self-citationGarcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Fitness‐compensatory mutations in rifampicin‐resistant RNA polymerase
Brandis, G., Wrande, M., Liljas, L., & Hughes, D. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08099.x · Cited by 161
Björkman, J., Samuelsson, P., Andersson, D. I., & Hughes, D. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01142.x · Cited by 151
Self-citationFitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae
Rozen, D. E., McGee, L., Levin, B. R., & Klugman, K. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-06 · Cited by 151
Context matters — the complex interplay between resistome genotypes and resistance phenotypes
Dantas, G. A., & Sommer, M. O. A. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.07.004 · Cited by 144
Self-citationFitness of antibiotic-resistant microorganisms and compensatory mutations
Böttger, E. C., Springer, B., Pletschette, M., & Sander, P. (1998) · Nature Medicine · doi:10.1038/3906 · Cited by 138
Evolutionary Paths That Expand Plasmid Host-Range: Implications for Spread of Antibiotic Resistance
Loftie‐Eaton, W., Yano, H., Burleigh, S., Simmons, R. S., Hughes, J. M., Rogers, L. M., Hunter, S. S., Settles, M. L., Forney, L. J., Ponciano, J. M., et al. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv339 · Cited by 134
Acquired Inducible Antimicrobial Resistance in Gram-Positive Bacteria
Chancey, S. T., Zähner, D., & Stephens, D. S. (2012) · Future Microbiology · doi:10.2217/fmb.12.63 · Cited by 133
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro
Heisig, P., & Tschorny, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1284 · Cited by 132
Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance
Chevereau, G., Dravecká, M., Batur, T., Güvenek, A., Ayhan, D. H., Toprak, E., & Bollenbach, T. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002299 · Cited by 126
O’Neill, A. J., Huovinen, T., Fishwick, C. W. G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.298-309.2006 · Cited by 124
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci
Foucault, M.-L., Depardieu, F., Courvalin, P. M., & Grillot‐Courvalin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006855107 · Cited by 121
Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations
Silva, R. F. M., Mendonça, S. C. M., Carvalho, L., Reis, A. M., Gordo, I., Trindade, S., & Dionísio, F. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002181 · Cited by 118
Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli
Huseby, D., Pietsch, F., Brandis, G., Garoff, L., Tegehall, A., & Hughes, D. (2017) · Molecular biology and evolution · doi:10.1093/molbev/msx052 · Cited by 110
Topological features of rugged fitness landscapes in sequence space
Kondrashov, D. A., & Kondrashov, F. A. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.09.009 · Cited by 106
Thulin, E., Sundqvist, M., & Andersson, D. I. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04819-14 · Cited by 103
Self-citationBrandis, G., & Hughes, D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt224 · Cited by 103
Shcherbakov, D., Akbergenov, R., Matt, T., Sander, P., Andersson, D. I., & Böttger, E. C. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07218.x · Cited by 100
Self-citationA theoretical and experimental analysis of bacterial growth in the bladder
Gordon, D. M., & Riley, M. A. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01500.x · Cited by 98
Vogwill, T., Kojadinovic, M., & MacLean, R. C. (2016) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2016.0151 · Cited by 93
Characterization of ESBL disseminating plasmids
Brolund, A., & Sandegren, L. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1062536 · Cited by 88
The Dynamic Structure of EF-G Studied by Fusidic Acid Resistance and Internal Revertants
Johanson, U., Aevarsson, A., Liljas, A., et al. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0259 · Cited by 78
EPISTASIS BUFFERS THE FITNESS EFFECTS OF RIFAMPICIN- RESISTANCE MUTATIONS IN PSEUDOMONAS AERUGINOSA
Hall, A. R., & MacLean, R. C. (2011) · Evolution · doi:10.1111/j.1558-5646.2011.01302.x · Cited by 68
Tomenius, H. L., Pränting, M., Thulin, E., & Andersson, D. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068875 · Cited by 66
Self-citationAlteration of ribosomal protein L6 in mutants of Escherichia coli resistant to gentamicin
Buckel, P., Buchberger, A., Böck, A., & Wittmann, H. G. (1977) · Molecular and General Genetics MGG · doi:10.1007/bf00455118 · Cited by 66
Périchon, B., & Courvalin, P. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00410-06 · Cited by 66
Adler, M., Anjum, M., Andersson, D. I., & Sandegren, L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks368 · Cited by 65
Self-citationSuppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1
Drusano, G. L., Louie, A., MacGowan, A. P., & Hope, W. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02177-15 · Cited by 64
Functional Metagenomic Investigations of the Human Intestinal Microbiota
Moore, A. M., Munck, C., Sommer, M. O. A., & Dantas, G. A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00188 · Cited by 60
Self-citationBrandis, G., Pietsch, F., Alemayehu, R., & Hughes, D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku434 · Cited by 60
Prioritizing risks of antibiotic resistance genes in all metagenomes
Martínez, J. L., Coque, T. M., & Baquero, F. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3399-c2 · Cited by 58
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2
Drusano, G. L., Hope, W. W., MacGowan, A. P., & Louie, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02231-15 · Cited by 55
Mutant ribosomes can generate dominant kirromycin resistance
Tubulekas, I., Buckingham, R. H., & Hughes, D. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.12.3635-3643.1991 · Cited by 48
The cost of antibiotic resistance depends on evolutionary history in Escherichia coli
Angst, D. C., & Hall, A. R. (2013) · BMC Evolutionary Biology · doi:10.1186/1471-2148-13-163 · Cited by 43
Genetic Complexity of Fusidic Acid-Resistant Small Colony Variants (SCV) in Staphylococcus aureus
Lannergård, J., Cao, S., Norström, T., Delgado, A., Gustafson, J. E., & Hughes, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028366 · Cited by 30
Origin inAcinetobacter gyllenbergiiand dissemination of aminoglycoside-modifying enzyme AAC(6′)-Ih
Yoon, E.-J., Goussard, S., Nemec, A., Lambert, T., Courvalin, P. M., & Grillot‐Courvalin, C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv390 · Cited by 17
Epistasis buffers the fitness effects of rifampicin-resistance mutations inPseudomonas aeruginosa
Hall, A. R., & MacLean, R. C. (2016) · Evolution · doi:10.1111/evo.12918 · Cited by 3
Cited by
Antibiotic resistance in the environment
Larsson, D. G. J., & Flach, C.-F. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00649-x · Cited by 3,164
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution
Botelho, J., Grosso, F., & Peixe, L. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.07.002 · Cited by 550
Supramolecular Antibacterial Materials for Combatting Antibiotic Resistance
Li, X., Bai, H., Yang, Y., Yoon, J., Wang, S., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201805092 · Cited by 542
Promoting Role of MXene Nanosheets in Biomedical Sciences: Therapeutic and Biosensing Innovations
Soleymaniha, M., Shahbazi, M., Rafieerad, A. R., Maleki, A., & Amiri, A. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801137 · Cited by 400
Metadata
- Authors
- Sommer, M. O. A., Munck, C., Toft-Kehler, R. V., & Andersson, D. I.
- Venue
- Nature Reviews Microbiology
- Published
- 2017-07-31
- Volume
- 15
- Issue
- 11
- Pages
- 689-696
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2740172058
- Cited by
- 301
- References
- 91
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.